Status:
ACTIVE_NOT_RECRUITING
Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome
Lead Sponsor:
Northwestern University
Conditions:
Chronic Pelvic Pain
Eligibility:
MALE
21-80 years
Brief Summary
This study seeks to identify defects in immune activation or regulation that may affect a subset of patients with CP/CPPS. This subset appears to have a reduced ability to mount a regulatory immune re...
Detailed Description
CPPS is a condition that is estimated to affect up to 15% of the male population with most diagnoses between the ages of 35-45. Designated by the presence of pain in the absence of bacterial infection...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Control Group:
- • Healthy males ages 21-80 years old
Exclusion
- Exclusion Criteria for Control Group:
- Females
- Males \<21 and \>80 years old
- Patients with impaired renal or hepatic function.
Key Trial Info
Start Date :
October 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 11 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05185180
Start Date
October 11 2021
End Date
December 11 2025
Last Update
December 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611